[Federal Register Volume 63, Number 48 (Thursday, March 12, 1998)]
[Notices]
[Pages 12105-12106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-6302]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Special Programs Emphasis Panel of the Office of the Director; 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the following Special Programs Emphasis Panel of the Office of the 
Director, National Institutes of Health.
    The meeting will be open to the public to provide a forum in which 
individuals from Government, industry, and voluntary health 
organizations work together to finalize a report and to make 
recommendations on steps to coordinate rare disease research programs 
within existing research funds and resources. This report will be 
submitted to the Senate Appropriations Committee.
    A portion of the meeting on March 30 will be available for public 
comment. Anyone who would like to provide comments at this meeting 
should contact Dr. Stephen Groft, (301) 402-4336, Executive Secretary 
of the Advisory Group of the Coordination of Rare Diseases Research.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.

    Name of Panel: Advisory Group of the Coordination of Rare 
Diseases Research.
    Dates of Meeting: March 30, 1998.
    Time of Meeting: 8:30 a.m.
    Place of Meeting: Wilson Hall, Shannon Building, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892.
    Agenda: To review the Draft Report on the Coordination of Rare 
Diseases Research and to Discuss Implementation Plans for the 
Recommendations.
    Contact Person: Dr. Stephen C. Groft (Executive Secretary), 
Director, Office of Rare Diseases, National Institutes of Health, 
Building 31, Room 1B03, 9000 Rockville Pike, Bethesda, MD 20892-
2082, Telephone: (301) 402-4336, Fax: (301) 402-0420.


[[Page 12106]]


    Dated: March 3, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 98-6302 Filed 3-11-98; 8:45 am]
BILLING CODE 4140-01-M